Literature DB >> 8884190

Sexual transmission of hepatitis C virus infection.

G Scotto1, A M Savastano, V Fazio, P E Conte, S Ferrara, A Mangano, G Tantimonaco.   

Abstract

The role of sexual transmission in the diffusion of HCV infection, was studied through the seroprevalence of anti-HCV antibodies in the heterosexual habitual partners of 83 anti-HCV positive subjects. The index cases were represented by 10 dialysed subjects, 31 patients with chronic liver disease and 42 healthy carriers. Seroprevalence of anti-HCV positivity reported in partners was 8.43%, with a higher rate in cohabitants of patients with chronic liver disease (16.12% vs 4.76% of carriers); no case was found among partners of dialysed subjects Laboratory and ultrasonograph signs of chronic hepatitis were reported in 3 cases (3.61%). Control on 70% of the cohabitants' relatives, was negative for HCV infections. These data suggest a possible sexual transmission of HCV infection, even if its prevalence resulted modest, undoubtedly lower than in other disease sexually transmitted.

Entities:  

Mesh:

Year:  1996        PMID: 8884190     DOI: 10.1007/bf00145412

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  16 in total

1.  Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome.

Authors:  Q L Choo; G Kuo; A J Weiner; L R Overby; D W Bradley; M Houghton
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728

2.  Hepatitis C virus: evidence for sexual transmission.

Authors:  R S Tedder; R J Gilson; M Briggs; C Loveday; C H Cameron; J A Garson; G E Kelly; I V Weller
Journal:  BMJ       Date:  1991-06-01

Review 3.  Molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of viral disease.

Authors:  M Houghton; A Weiner; J Han; G Kuo; Q L Choo
Journal:  Hepatology       Date:  1991-08       Impact factor: 17.425

4.  Possibility of heterosexual transmission of hepatitis C virus.

Authors:  G Cilla; E Pérez-Trallero; M Iturriza; J Arrizabalaga; J A Iribarren
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-06       Impact factor: 3.267

5.  Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection.

Authors:  M J Alter; S C Hadler; F N Judson; A Mares; W J Alexander; P Y Hu; J K Miller; L A Moyer; H A Fields; D W Bradley
Journal:  JAMA       Date:  1990-11-07       Impact factor: 56.272

6.  Sexual transmission of hepatitis C virus and its relation with hepatitis B virus and HIV.

Authors:  J Tor; J M Llibre; M Carbonell; R Muga; A Ribera; V Soriano; B Clotet; M Sabriá; M Foz
Journal:  BMJ       Date:  1990-11-17

7.  The low risk of hepatitis C virus transmission among sexual partners of hepatitis C-infected hemophilic males: an international, multicenter study.

Authors:  D B Brettler; P M Mannucci; A Gringeri; J E Rasko; A D Forsberg; M G Rumi; R J Garsia; K A Rickard; M Colombo
Journal:  Blood       Date:  1992-07-15       Impact factor: 22.113

8.  Seroepidemiologic study of hepatitis C virus in sexually transmitted disease risk groups.

Authors:  A Stary; W Kopp; H Hofmann; C Heller-Vitouch; C Kunz
Journal:  Sex Transm Dis       Date:  1992 Sep-Oct       Impact factor: 2.830

9.  Intrafamilial transmission of hepatitis C virus: the important role of infections between spouses.

Authors:  J H Kao; P J Chen; P M Yang; M Y Lai; J C Sheu; T H Wang; D S Chen
Journal:  J Infect Dis       Date:  1992-10       Impact factor: 5.226

10.  Heterosexual co-transmission of hepatitis C virus (HCV) and human immunodeficiency virus (HIV).

Authors:  M E Eyster; H J Alter; L M Aledort; S Quan; A Hatzakis; J J Goedert
Journal:  Ann Intern Med       Date:  1991-11-15       Impact factor: 25.391

View more
  1 in total

1.  A study on the role of the family and other risk factors in HCV transmission.

Authors:  S Brusaferro; F Barbone; P Andrian; G Brianti; L Ciccone; A Furlan; D Gnesutta; S Stel; E Zamparo; P Toniutto; P Ferroni; V Gasparini
Journal:  Eur J Epidemiol       Date:  1999-02       Impact factor: 8.082

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.